Mostrar el registro sencillo del ítem
Tigecycline reduces tumorigenesis in colorectal cancer via inhibition of cell proliferation and modulation of immune response
dc.contributor.author | Ruiz Malagón, Antonio Jesús | |
dc.contributor.author | Hidalgo García, Laura | |
dc.contributor.author | Rodríguez Sojo, María Jesús | |
dc.contributor.author | Molina Tijeras, José Alberto | |
dc.contributor.author | Díez Echave, Patricia | |
dc.contributor.author | Vezza, Teresa | |
dc.contributor.author | Rodríguez Cabezas, María Elena | |
dc.contributor.author | Rodríguez Nogales, Alba | |
dc.contributor.author | Gálvez Peralta, Julio Juan | |
dc.date.accessioned | 2023-06-29T10:08:11Z | |
dc.date.available | 2023-06-29T10:08:11Z | |
dc.date.issued | 2023-04-27 | |
dc.identifier.citation | A.J. Ruiz-Malagón et al. Tigecycline reduces tumorigenesis in colorectal cancer via inhibition of cell proliferation and modulation of immune response. Biomedicine & Pharmacotherapy 163 (2023) 114760[https://doi.org/10.1016/j.biopha.2023.114760] | es_ES |
dc.identifier.uri | https://hdl.handle.net/10481/82946 | |
dc.description.sponsorship | Junta de Andalucía (CTS 164) | es_ES |
dc.description.sponsorship | Instituto de Salud Carlos III (Spain) | es_ES |
dc.description.sponsorship | Fondo Europeo de Desarrollo Regional (FEDER) | es_ES |
dc.description.sponsorship | European Union, through the research grants PI18/00826, P18-RT-4930, PI0206–2016, PIE16/00045 and PI19/01058 | es_ES |
dc.description.sponsorship | Spanish Ministry of Science and Innovation (MCIN/AEI/ 10.13039/501100011033/FEDER) | es_ES |
dc.description.sponsorship | RTI2018–101309-BC22 | es_ES |
dc.description.sponsorship | Chair “Doctors Galera-Requena in cancer stem cell research” (CMC-CTS963 | es_ES |
dc.description.sponsorship | Spanish Ministry of Science and Innovation (“Programa de Doctorado: Medicina Clínica y Salud Pública” B12.56.1). | es_ES |
dc.description.sponsorship | Instituto de Salud Carlos III (FI17/00176) | es_ES |
dc.description.sponsorship | Junta de Andalucía (P18-RT-4930) | es_ES |
dc.description.sponsorship | University of Granada | es_ES |
dc.description.sponsorship | CIBER-EHD is funded by the Instituto de Salud Carlos III | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Elsevier | es_ES |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Colitis-associated colorectal cancer | es_ES |
dc.subject | Tigecycline | es_ES |
dc.subject | β-catenin | es_ES |
dc.subject | Cytotoxic T lymphocytes | es_ES |
dc.subject | Microbiota | es_ES |
dc.title | Tigecycline reduces tumorigenesis in colorectal cancer via inhibition of cell proliferation and modulation of immune response | es_ES |
dc.type | journal article | es_ES |
dc.rights.accessRights | open access | es_ES |
dc.identifier.doi | 10.1016/j.biopha.2023.114760 | |
dc.type.hasVersion | VoR | es_ES |